These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20926701)

  • 1. Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.
    Frandoloso R; Martínez S; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Martínez-Fernández B; Gutiérrez-Martín CB
    Clin Vaccine Immunol; 2011 Jan; 18(1):50-8. PubMed ID: 20926701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute phase protein concentrations in colostrum-deprived pigs immunized with subunit and commercial vaccines against Glässer's disease.
    Martínez-Martínez S; Frandoloso R; Gutiérrez-Martín CB; Lampreave F; García-Iglesias MJ; Pérez-Martínez C; Rodríguez-Ferri EF
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):61-7. PubMed ID: 21816489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs.
    Huang X; Li Y; Fu Y; Ji Y; Lian K; Zheng H; Wei J; Cai X; Zhu Q
    Clin Vaccine Immunol; 2013 Jun; 20(6):912-9. PubMed ID: 23616407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
    Hau SJ; Eberle KC; Brockmeier SL
    Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoproteomic analysis of the protective response obtained with subunit and commercial vaccines against Glässer's disease in pigs.
    Martínez-Martínez S; Frandoloso R; Rodríguez Ferri EF; Gil C; Hernández-Haro C; Yubero S; Gutiérrez Martín CB
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):235-47. PubMed ID: 23266097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic characterization of vaccines based on Haemophilus parasuis Nagasaki strain, OmpP2, OmpP5 and OmpD15, in colostrum-deprived pigs experimentally challenged with the same strain.
    Álvarez-Estrada Á; Martínez-Martínez S; Martín CG; García-Iglesias MJ; Pérez-Martínez C; Yubero-Delgado S; Guizzo JA; Frandoloso R; Rodríguez-Ferri EF
    Res Vet Sci; 2018 Aug; 119():292-301. PubMed ID: 30081339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.
    Hau SJ; Luan SL; Loving CL; Nicholson TL; Wang J; Peters SE; Seilly D; Weinert LA; Langford PR; Rycroft AN; Wren BW; Maskell DJ; Tucker AW; Brockmeier SL;
    BMC Vet Res; 2020 May; 16(1):167. PubMed ID: 32460764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in cellular immune response in colostrum-deprived pigs after immunization with subunit and commercial vaccines against Glässer's disease.
    Frandoloso R; Martínez-Martínez S; Yubero S; Rodríguez-Ferri EF; Gutiérrez-Martín CB
    Cell Immunol; 2012; 277(1-2):74-82. PubMed ID: 22721860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic antibody response in colostrum-deprived pigs experimentally infected with Haemophilus parasuis.
    Martín de la Fuente AJ; Rodríguez-Ferri EF; Frandoloso R; Martínez S; Tejerina F; Gutiérrez-Martín CB
    Res Vet Sci; 2009 Apr; 86(2):248-53. PubMed ID: 18783805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
    Zheng X; Yang X; Li X; Qiu GH; Dai A; Huang Q; Huang C; Guo X
    Vaccine; 2017 Mar; 35(10):1417-1423. PubMed ID: 28187951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood cellular immune response in pigs immunized and challenged with Haemophilus parasuis.
    de la Fuente AJ; Gutiérrez-Martín CB; Rodríguez-Barbosa JI; Martínez-Martínez S; Frandoloso R; Tejerina F; Rodríguez-Ferri EF
    Res Vet Sci; 2009 Apr; 86(2):230-4. PubMed ID: 18783806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First comparison of adjuvant for trivalent inactivated Haemophilus parasuis serovars 4, 5 and 12 vaccines against Glässer's disease.
    Xue Q; Zhao Z; Liu H; Chen K; Xue Y; Wang L
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):153-8. PubMed ID: 26672914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vaccine based on a mutant transferrin binding protein B of Haemophilus parasuis induces a strong T-helper 2 response and bacterial clearance after experimental infection.
    Martínez-Martínez S; Frandoloso R; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Álvarez-Estrada Á; Gutiérrez-Martín CB
    Vet Immunol Immunopathol; 2016 Oct; 179():18-25. PubMed ID: 27590421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different vaccine formulations on the development of Glässer's disease induced in pigs by experimental Haemophilus parasuis infection.
    Martín de la Fuente AJ; Gutiérrez Martín CB; Pérez Martínez C; García Iglesias MJ; Tejerina F; Rodríguez Ferri EF
    J Comp Pathol; 2009; 140(2-3):169-76. PubMed ID: 19135210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of efficacy obtained with a trivalent inactivated
    Zhao Z; Liu H; Xue Y; Chen K; Liu Z; Xue Q; Wang C
    Can J Vet Res; 2017 Jan; 81(1):22-27. PubMed ID: 28154458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5.
    Zhou M; Guo Y; Zhao J; Hu Q; Hu Y; Zhang A; Chen H; Jin M
    Vaccine; 2009 Aug; 27(38):5271-7. PubMed ID: 19576561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA).
    Olvera A; Pina S; Pérez-Simó M; Aragón V; Segalés J; Bensaid A
    Vaccine; 2011 Mar; 29(15):2797-802. PubMed ID: 21320547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and antigenic characterization of three recombinant proteins with potential for Glässer's disease prevention.
    Li M; Li C; Song S; Kang H; Yang D; Li G
    Vaccine; 2016 Apr; 34(19):2251-8. PubMed ID: 26993332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights about functional and cross-reactive properties of antibodies generated against recombinant TbpBs of Haemophilus parasuis.
    Barasuol BM; Guizzo JA; Fegan JE; Martínez-Martínez S; Rodríguez-Ferri EF; Gutiérrez-Martín CB; Kreutz LC; Schryvers AB; Frandoloso R
    Sci Rep; 2017 Sep; 7(1):10377. PubMed ID: 28871190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigens.
    Álvarez-Estrada Á; Gutiérrez-Martín CB; Rodríguez-Ferri EF; Martínez-Martínez S
    BMC Vet Res; 2018 Nov; 14(1):326. PubMed ID: 30400794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.